Dräger, Nina M.
Sattler, Sydney M.
Huang, Cindy Tzu-Ling
Teter, Olivia M.
Leng, Kun
Hashemi, Sayed Hadi
Hong, Jason
Aviles, Giovanni
Clelland, Claire D. http://orcid.org/0000-0002-9112-2278
Zhan, Lihong
Udeochu, Joe C.
Kodama, Lay http://orcid.org/0000-0001-8419-8445
Singleton, Andrew B.
Nalls, Mike A.
Ichida, Justin
Ward, Michael E. http://orcid.org/0000-0002-5296-8051
Faghri, Faraz http://orcid.org/0000-0001-5744-8728
Gan, Li http://orcid.org/0000-0003-4600-275X
Kampmann, Martin http://orcid.org/0000-0002-3819-7019
Funding for this research was provided by:
National Science Foundation (Graduate Research Fellowship)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (F30 AG066418, F30 AG062043, R01 AG051390)
U.S. Department of Health & Human Services | National Institutes of Health (ZO1 AG000534-02)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (U54 NS100717, U54 NS100717)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (DP2 GM119139)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01 MH115747)
Article History
Received: 22 June 2021
Accepted: 24 June 2022
First Online: 11 August 2022
Competing interests
: M.A.N. consults for Neuron23. M.A.N. and F.F. participated in this work in part due to a competitively awarded consulting contract between Data Tecnica International, LLC and the National Institutes of Health (USA). J.I. is a cofounder of AcuraStem, Inc. and Modulo Bio, and serves on the scientific advisory board of Spinogenix. L.G. is a founder of Aeton Therapeutics. M.K. is an inventor on US patent 11,254,933 related to CRISPRi and CRISPRa screening; serves on the scientific advisory boards of Engine Biosciences, Casma Therapeutics, Cajal Neuroscience and Alector; and is a consultant to Modulo Bio and Recursion Therapeutics. The remaining authors declare no competing interests.